Preclinical evaluation of Vaxfectin(®)-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

Increasing the potency and supply of seasonal and pandemic influenza vaccines remains an important unmet medical need which may be effectively accomplished with adjuvanted egg- or cell culture-derived vaccines. Vaxfectin(®), a cationic lipid-based adjuvant with a favorable safety profile in phase 1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, Larry R., Wodal, Walter, Crowe, Brian A., Kerschbaum, Astrid, Bruehl, Peter, Schwendinger, Michael G., Savidis-Dacho, Helga, Sullivan, Sean M., Shlapobersky, Mark, Hartikka, Jukka, Rolland, Alain, Barrett, P. Noel, Kistner, Otfried
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901827/
https://ncbi.nlm.nih.gov/pubmed/23857272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.24209
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars